NeoGenomics Inc

NAS:NEO (USA)  
$ 15.80 -0.682 (-4.14%) 12:33 PM EST
At Loss
P/B:
2.23
Volume:
712.50K
Avg Vol (2M):
1.11M
Also Trade In:
Volume:
712.50K
At Loss
Avg Vol (2M):
1.11M

Business Description

NeoGenomics Inc
NAICS : 541714 SIC : 8734
ISIN : US64049M2098
Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
Name Current Vs Industry Vs History
Cash-To-Debt 0.68
Equity-to-Asset 0.56
Debt-to-Equity 0.65
Debt-to-EBITDA -34.74
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.03
Distress
Grey
Safe
Beneish M-Score -2.66
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 78.97
9-Day RSI 67.42
14-Day RSI 59.93
6-1 Month Momentum % 11.72
12-1 Month Momentum % 19.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.2
Quick Ratio 5.95
Cash Ratio 4.31
Days Inventory 25.63
Days Sales Outstanding 77.47
Days Payable 20.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.4
Shareholder Yield % -0.1

Financials (Next Earnings Date:2024-05-08 Est.)

NEO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NEO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

NeoGenomics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 591.643
EPS (TTM) ($) -0.7
Beta 1.39
Volatility % 66.49
14-Day RSI 59.93
14-Day ATR ($) 0.739581
20-Day SMA ($) 14.92225
12-1 Month Momentum % 19.62
52-Week Range ($) 11.03 - 21.22
Shares Outstanding (Mil) 127.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NeoGenomics Inc Filings

Filing Date Document Date Form
No Filing Data

NeoGenomics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

NeoGenomics Inc Frequently Asked Questions

What is NeoGenomics Inc(NEO)'s stock price today?
The current price of NEO is $15.80. The 52 week high of NEO is $21.22 and 52 week low is $11.03.
When is next earnings date of NeoGenomics Inc(NEO)?
The next earnings date of NeoGenomics Inc(NEO) is 2024-05-08 Est..
Does NeoGenomics Inc(NEO) pay dividends? If so, how much?
NeoGenomics Inc(NEO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1